A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Clinical trial NCT06615193 · RECRUITING

Trial details

NCT number: NCT06615193
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Refractory Lymphoma Relapsed Hematologic Malignancy

Start date: 2024-08-12
Primary completion: 2026-06-24
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.